Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= MAFF ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: MAFF * **<color #00a2e8>Official Name</color>**: MAF bZIP transcription factor F * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23764|23764]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q9ULX9|Q9ULX9]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=MAFF&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MAFF|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/604877|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: N/A * **<color #00a2e8>UniProt Summary</color>**: Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves (PubMed:8932385). However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as NFE2L1/NRF1, and recruiting them to specific DNA-binding sites. Interacts with the upstream promoter region of the oxytocin receptor gene (PubMed:8932385, PubMed:16549056). May be a transcriptional enhancer in the up- regulation of the oxytocin receptor gene at parturition (PubMed:10527846). {ECO:0000269|PubMed:10527846, ECO:0000269|PubMed:16549056, ECO:0000269|PubMed:8932385}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |bZIP Maf| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |parturition| |skeletal muscle cell differentiation| |regulation of epidermal cell differentiation| |regulation of epidermis development| |skeletal muscle tissue development| |skeletal muscle organ development| |regulation of epithelial cell differentiation| |multi-multicellular organism process| |striated muscle tissue development| |blood coagulation| |coagulation| |muscle organ development| |muscle tissue development| |hemostasis| |in utero embryonic development| |sequence-specific DNA binding| |DNA-binding transcription activator activity, RNA polymerase II-specific| |muscle structure development| |wound healing| |transcription by RNA polymerase II| |regulation of body fluid levels| |RNA polymerase II proximal promoter sequence-specific DNA binding| |response to wounding| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |DNA-binding transcription factor activity| |embryo development| |multi-organism reproductive process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |mitochondrion| |organic cyclic compound biosynthetic process| |reproductive process| |reproduction| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.53| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.11| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-1.85| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.78| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.428| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 5907 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 3.06 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='MAFF Expression in NALM6 Cells: 3.06'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1